Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2021

Feb 17, 2021

30237_dirs_2021-02-17_4de0142a-8cd4-4b6b-afb6-745de3320730.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-02-12

Reporting Person: EISENBERG GLENN A (Chief Financial Officer, EVP)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-12 Common Stock M 780 Acquired 32558 Direct
2021-02-12 Common Stock F 232 $238.26 Disposed 32326 Direct
2021-02-12 Common Stock M 940 Acquired 33266 Direct
2021-02-12 Common Stock F 280 $238.26 Disposed 32986 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-12 Restricted Stock Unit $ M 780 Disposed Common Stock (780) Direct
2021-02-12 Restricted Stock Unit $ M 940 Disposed Common Stock (940) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: The Restricted Stock Units vested in three equal annual installments beginning on February 12, 2019 and are now fully vested.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F5: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020.